CN103923229A - 一种交联透明质酸钠及其制备方法 - Google Patents
一种交联透明质酸钠及其制备方法 Download PDFInfo
- Publication number
- CN103923229A CN103923229A CN201410180764.3A CN201410180764A CN103923229A CN 103923229 A CN103923229 A CN 103923229A CN 201410180764 A CN201410180764 A CN 201410180764A CN 103923229 A CN103923229 A CN 103923229A
- Authority
- CN
- China
- Prior art keywords
- preparation
- sodium
- hyaluronic acid
- cross
- polyoxyethylene polyoxypropylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title claims abstract description 105
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 229920002385 Sodium hyaluronate Polymers 0.000 title abstract description 7
- 229940010747 sodium hyaluronate Drugs 0.000 title abstract description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 66
- 238000004132 cross linking Methods 0.000 claims abstract description 63
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 11
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 10
- 229940059574 pentaerithrityl Drugs 0.000 claims description 40
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- 239000012065 filter cake Substances 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 28
- 239000011780 sodium chloride Substances 0.000 claims description 19
- 238000000108 ultra-filtration Methods 0.000 claims description 19
- 238000001556 precipitation Methods 0.000 claims description 18
- 238000012805 post-processing Methods 0.000 claims description 16
- 230000018044 dehydration Effects 0.000 claims description 10
- 238000006297 dehydration reaction Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 239000003431 cross linking reagent Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 229960003160 hyaluronic acid Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 3
- 229940099552 hyaluronan Drugs 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229930012538 Paclitaxel Natural products 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- -1 before reaction Chemical compound 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229960001592 paclitaxel Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410180764.3A CN103923229B (zh) | 2014-04-30 | 2014-04-30 | 一种交联透明质酸钠及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410180764.3A CN103923229B (zh) | 2014-04-30 | 2014-04-30 | 一种交联透明质酸钠及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103923229A true CN103923229A (zh) | 2014-07-16 |
CN103923229B CN103923229B (zh) | 2016-02-03 |
Family
ID=51141641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410180764.3A Expired - Fee Related CN103923229B (zh) | 2014-04-30 | 2014-04-30 | 一种交联透明质酸钠及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103923229B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106397846A (zh) * | 2016-08-31 | 2017-02-15 | 北京大清生物技术有限公司 | 一种交联透明质酸钠及其制备方法与应用 |
CN107540763A (zh) * | 2016-06-24 | 2018-01-05 | 宁夏妙朗生物科技有限公司 | 一种利用生物交联剂制备注射型长效透明质酸凝胶的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1419792A1 (en) * | 2001-08-21 | 2004-05-19 | Japan Science and Technology Agency | Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
CN101790542A (zh) * | 2007-07-30 | 2010-07-28 | 阿勒根公司 | 经可调交联的透明质酸组合物 |
CN103146003A (zh) * | 2013-03-06 | 2013-06-12 | 上海其胜生物制剂有限公司 | 一种低温二次交联透明质酸钠凝胶的制备方法 |
-
2014
- 2014-04-30 CN CN201410180764.3A patent/CN103923229B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1419792A1 (en) * | 2001-08-21 | 2004-05-19 | Japan Science and Technology Agency | Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
CN101790542A (zh) * | 2007-07-30 | 2010-07-28 | 阿勒根公司 | 经可调交联的透明质酸组合物 |
CN103146003A (zh) * | 2013-03-06 | 2013-06-12 | 上海其胜生物制剂有限公司 | 一种低温二次交联透明质酸钠凝胶的制备方法 |
Non-Patent Citations (3)
Title |
---|
吕正兵: "《生物工程制药学》", 30 June 2012, 科学出版社 * |
崔羽佳: "新型交联透明质酸钠凝胶的制备及其性能研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 * |
顾其胜 等: "《透明质酸与临床医学》", 30 November 2013, 第二军医大学出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107540763A (zh) * | 2016-06-24 | 2018-01-05 | 宁夏妙朗生物科技有限公司 | 一种利用生物交联剂制备注射型长效透明质酸凝胶的方法 |
CN107540763B (zh) * | 2016-06-24 | 2020-08-11 | 宁夏妙朗生物科技有限公司 | 一种利用生物交联剂制备注射型长效透明质酸凝胶的方法 |
CN106397846A (zh) * | 2016-08-31 | 2017-02-15 | 北京大清生物技术有限公司 | 一种交联透明质酸钠及其制备方法与应用 |
CN106397846B (zh) * | 2016-08-31 | 2019-07-12 | 北京大清生物技术股份有限公司 | 一种交联透明质酸钠及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103923229B (zh) | 2016-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Bioactive polysaccharides from natural resources including Chinese medicinal herbs on tissue repair | |
Ma et al. | In vitro and in vivo anticoagulant activity of heparin-like biomacromolecules and the mechanism analysis for heparin-mimicking activity | |
JP6432709B2 (ja) | ポリ硫酸ペントサンの製造方法 | |
JP6281659B1 (ja) | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 | |
US20080188585A1 (en) | Photocrosslinked-polysaccharide composition and production process of the same | |
CN101538377A (zh) | 一种交联透明质酸凝胶及其制备方法 | |
ITPD20000208A1 (it) | Polisaccaridi percarbossilati, processo per la loro preparazione e loro impiego in campo farmaceutico e biomedico-sanitario. | |
Chen et al. | Structure and properties of a (1→ 3)-β-d-glucan from ultrasound-degraded exopolysaccharides of a medicinal fungus | |
JPWO2009041627A1 (ja) | 膨潤性架橋ヒアルロン酸粉末及びその製造方法 | |
Shao et al. | Pharmacokinetics and biodegradation performance of a hydroxypropyl chitosan derivative | |
WO2007059890A1 (en) | New derivatives of hyaluronic acid, their preparation process and their uses | |
de Souza et al. | Effect of pH variation and crosslinker absence on the gelling mechanism of high acyl gellan: Morphological, thermal and mechanical approaches | |
CN103923229B (zh) | 一种交联透明质酸钠及其制备方法 | |
Duceac et al. | Insights on some polysaccharide gel type materials and their structural peculiarities | |
RU2512768C1 (ru) | Способ получения низкомолекулярного гепарина | |
Guo et al. | Macromolecular and thermokinetic properties of a galactomannan from Sophora alopecuroides L. seeds: A study of molecular aggregation | |
Zhou et al. | A wet-adhesive carboxymethylated yeast β-glucan sponge with radical scavenging, bacteriostasis and anti-inflammatory functions for rapid hemostasis | |
CN104231285A (zh) | 透明质酸衍生物凝胶及其制备方法 | |
US10414833B2 (en) | Biocompatible composition and method for preparing same | |
CN103319627A (zh) | 一种对透明质酸钠进行分子量分级的方法 | |
Ramos et al. | Poly (ethylene glycol)-crosslinked N-methylene phosphonic chitosan. Preparation and characterization | |
KR102226724B1 (ko) | 물리적 반응에 의한 히알루론산 하이드로겔의 제조 방법 | |
JP2007063400A (ja) | アオヤギ由来のコンドロイチン硫酸 | |
CN114585652B (zh) | 在有机溶剂中进行的透明质酸钠盐纯化方法 | |
CN115703846B (zh) | 一种透明质酸衍生物的纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU JINNUO BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SUZHOU YOUNINGKANG INFORMATION TECHNOLOGY CO., LTD. Effective date: 20150331 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215000 SUZHOU, JIANGSU PROVINCE TO: 215400 SUZHOU, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150331 Address after: 215400 Taicang Economic Development Zone, Jiangsu, Beijing West Road, No. 6, No. Applicant after: SUZHOU JINNUO BIOTECHNOLOGY Co.,Ltd. Address before: 706, room 1, building 225, Star Rainbow Building, No. 215000 middle Rainbow Road, Suzhou Industrial Park, Jiangsu, Suzhou Applicant before: SUZHOU YOUNINGKANG INFORMATION TECHNOLOGY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190618 Address after: 215400 Room 103, Building 11, West Nanyuan Road, Chengxiang Town, Taicang City, Suzhou City, Jiangsu Province Patentee after: Guo Huijun Address before: 215400 6 Beijing West Road, Taicang Economic Development Zone, Suzhou, Jiangsu Patentee before: SUZHOU JINNUO BIOTECHNOLOGY Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160203 |